Literature DB >> 33373023

Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn's disease.

Corinna Lang-Schwarz1, Abbas Agaimy2, Raja Atreya3,4, Christoph Becker3,4, Silvio Danese5, Jean-François Fléjou6, Nikolaus Gaßler7, Heike I Grabsch8,9, Arndt Hartmann2, Kateřina Kamarádová10, Anja A Kühl4,11, Gregory Y Lauwers12, Alessandro Lugli13, Iris Nagtegaal14, Markus F Neurath3,4, Georg Oberhuber15, Laurent Peyrin-Biroulet16, Timo Rath3, Robert Riddell17, Carlos A Rubio18, Kieran Sheahan19, Herbert Tilg20, Vincenzo Villanacci21, Maria Westerhoff22, Michael Vieth23,24.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33373023      PMCID: PMC7973393          DOI: 10.1007/s00428-020-02982-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  115 in total

1.  Development and validation of a histological index for UC.

Authors:  Mahmoud H Mosli; Brian G Feagan; Guangyong Zou; William J Sandborn; Geert D'Haens; Reena Khanna; Lisa M Shackelton; Christopher W Walker; Sigrid Nelson; Margaret K Vandervoort; Valerie Frisbie; Mark A Samaan; Vipul Jairath; David K Driman; Karel Geboes; Mark A Valasek; Rish K Pai; Gregory Y Lauwers; Robert Riddell; Larry W Stitt; Barrett G Levesque
Journal:  Gut       Date:  2015-10-16       Impact factor: 23.059

Review 2.  Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.

Authors:  Mahmoud H Mosli; Brian G Feagan; William J Sandborn; Geert Dʼhaens; Cynthia Behling; Keith Kaplan; David K Driman; Lisa M Shackelton; Kenneth A Baker; John K Macdonald; Margaret K Vandervoort; Karel Geboes; Barrett G Levesque
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

3.  Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

Authors:  Walter Reinisch; Sieglinde Angelberger; Wolfgang Petritsch; Olga Shonova; Milan Lukas; Simon Bar-Meir; Alexander Teml; Elke Schaeffeler; Matthias Schwab; Karin Dilger; Roland Greinwald; Ralph Mueller; Eduard F Stange; Klaus R Herrlinger
Journal:  Gut       Date:  2010-06       Impact factor: 23.059

4.  Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.

Authors:  Marco M Hefti; David B Chessin; Noam H Harpaz; Randolph M Steinhagen; Thomas A Ullman
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

5.  Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis.

Authors:  R Odze; D Antonioli; M Peppercorn; H Goldman
Journal:  Am J Surg Pathol       Date:  1993-09       Impact factor: 6.394

6.  European consensus on the histopathology of inflammatory bowel disease.

Authors:  F Magro; C Langner; A Driessen; A Ensari; K Geboes; G J Mantzaris; V Villanacci; G Becheanu; P Borralho Nunes; G Cathomas; W Fries; A Jouret-Mourin; C Mescoli; G de Petris; C A Rubio; N A Shepherd; M Vieth; R Eliakim
Journal:  J Crohns Colitis       Date:  2013-07-17       Impact factor: 9.071

7.  East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.

Authors:  J Burisch; N Pedersen; S Čuković-Čavka; M Brinar; I Kaimakliotis; D Duricova; O Shonová; I Vind; S Avnstrøm; N Thorsgaard; V Andersen; S Krabbe; J F Dahlerup; R Salupere; K R Nielsen; J Olsen; P Manninen; P Collin; E V Tsianos; K H Katsanos; K Ladefoged; L Lakatos; E Björnsson; G Ragnarsson; Y Bailey; S Odes; D Schwartz; M Martinato; G Lupinacci; M Milla; A De Padova; R D'Incà; M Beltrami; L Kupcinskas; G Kiudelis; S Turcan; O Tighineanu; I Mihu; F Magro; L F Barros; A Goldis; D Lazar; E Belousova; I Nikulina; V Hernandez; D Martinez-Ares; S Almer; Y Zhulina; J Halfvarson; N Arebi; S Sebastian; P L Lakatos; E Langholz; P Munkholm
Journal:  Gut       Date:  2013-04-20       Impact factor: 23.059

8.  The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease.

Authors:  M C Allison; S J Hamilton-Dutoit; A P Dhillon; R E Pounder
Journal:  Q J Med       Date:  1987-12

9.  Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.

Authors:  Geert R D'Haens; Severine Vermeire; Gert Van Assche; Maja Noman; Isolde Aerden; Gust Van Olmen; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2008-07-16       Impact factor: 22.682

10.  Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Authors:  Thomas Greuter; Alberto Piller; Nicolas Fournier; Ekaterina Safroneeva; Alex Straumann; Luc Biedermann; Sébastien Godat; Andreas Nydegger; Michael Scharl; Gerhard Rogler; Stephan R Vavricka; Alain M Schoepfer
Journal:  J Crohns Colitis       Date:  2018-11-28       Impact factor: 9.071

View more
  5 in total

1.  Dysplastic Crypts in Asymmetric Branching in Ulcerative Colitis: A Preliminary Report.

Authors:  Carlos A Rubio; Michael Vieth; Corinna Lang-Schwarz
Journal:  Cancer Diagn Progn       Date:  2022-05-03

2.  Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s Disease.

Authors:  Corinna Lang-Schwarz; Miriam Angeloni; Abbas Agaimy; Raja Atreya; Christoph Becker; Theresa Dregelies; Silvio Danese; Jean-François Fléjou; Nikolaus Gaßler; Heike I Grabsch; Arndt Hartmann; Kateřina Kamarádová; Anja A Kühl; Gregory Y Lauwers; Alessandro Lugli; Iris Nagtegaal; Markus F Neurath; Georg Oberhuber; Laurent Peyrin-Biroulet; Timo Rath; Robert Riddell; Carlos A Rubio; Kieran Sheahan; Britta Siegmund; Herbert Tilg; Vincenzo Villanacci; Maria Westerhoff; Fulvia Ferrazzi; Michael Vieth
Journal:  J Crohns Colitis       Date:  2021-10-07       Impact factor: 9.071

3.  Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability.

Authors:  A Caputo; P Parente; M Cadei; M Fassan; A Rispo; G Leoncini; G Bassotti; R Del Sordo; C Metelli; M Daperno; A Armuzzi; V Villanacci
Journal:  Tech Coloproctol       Date:  2022-06-01       Impact factor: 3.699

Review 4.  Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?

Authors:  Ondrej Fabian; Lukas Bajer
Journal:  World J Gastroenterol       Date:  2022-09-28       Impact factor: 5.374

5.  Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.

Authors:  Ashkan Rezazadeh Ardabili; Danny Goudkade; Dion Wintjens; Mariëlle Romberg-Camps; Bjorn Winkens; Marie Pierik; Heike I Grabsch; Daisy Jonkers
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.